The antibody gene mutator activation-induced cytidine deaminase (AID) promiscuously damages oncogenes, leading to chromosomal translocations and tumorigenesis. Why nonimmunoglobulin loci are susceptible to AID activity is unknown. Here, we study AID-mediated lesions in the context of nuclear architecture and the B cell regulome. We show that AID targets are not randomly distributed across the genome but are predominantly grouped within super-enhancers and regulatory clusters. Unexpectedly, in these domains, AID deaminates active promoters and eRNA + enhancers interconnected in some instances over megabases of linear chromatin. Using genome editing, we demonstrate that 3D-linked targets cooperate to recruit AID-mediated breaks. Furthermore, a comparison of hypermutation in mouse B cells, AID-induced kataegis in human lymphomas, and translocations in MEFs reveals that AID damages different genes in different cell types. Yet, in all cases, the targets are predominantly associated with topological complex, highly transcribed super-enhancers, demonstrating that these compartments are key mediators of AID recruitment.
The antibody gene mutator activation-induced cytidine deaminase (AID) promiscuously damages oncogenes, leading to chromosomal translocations and tumorigenesis. Why nonimmunoglobulin loci are susceptible to AID activity is unknown. Here, we study AID-mediated lesions in the context of nuclear architecture and the B cell regulome. We show that AID targets are not randomly distributed across the genome but are predominantly grouped within super-enhancers and regulatory clusters. Unexpectedly, in these domains, AID deaminates active promoters and eRNA + enhancers interconnected in some instances over megabases of linear chromatin. Using genome editing, we demonstrate that 3D-linked targets cooperate to recruit AID-mediated breaks. Furthermore, a comparison of hypermutation in mouse B cells, AID-induced kataegis in human lymphomas, and translocations in MEFs reveals that AID damages different genes in different cell types. Yet, in all cases, the targets are predominantly associated with topological complex, highly transcribed super-enhancers, demonstrating that these compartments are key mediators of AID recruitment.
INTRODUCTION
Although humans produce roughly equal numbers of B and T lymphocytes, up to 95% of lymphomas in the Western world are of B cell origin (Kü ppers, 2005) . This overrepresentation originates in large part from misrepair of DNA lesions introduced by activation-induced cytidine deaminase (AID), a B cell-specific cytidine deaminase that initiates class switch recombination (CSR) and somatic hypermutation (SHM) of immunoglobulin (Ig) genes (Alt et al., 2013) . Although AID preferentially targets Ig heavy and light chain loci, it also mutates and produces DNA breaks in non-Ig genes Liu et al., 2008; Robbiani et al., 2008) . Among these off targets, a substantial number are oncogenes directly implicated in B cell lymphomagenesis, including BCL6, Myc, MIR142, CD95, Pax5, and BCL7 (Chiarle et al., 2011; Hakim et al., 2012; Hasham et al., 2010; Kato et al., 2012; Klein et al., 2011; Mü schen et al., 2000; Pasqualucci et al., 1998; Robbiani et al., 2009; Shen et al., 1998; Tsai et al., 2008) . Recurrent DNA damage at these loci leads to oncogenic mutations and chromosomal translocations that activate proto-oncogenes by juxtaposing them to potent Ig enhancers (Nussenzweig and Nussenzweig, 2010) . Accordingly, genetic ablation of AID markedly impairs the formation of Ig-translocations and the onset of B cell tumor development in mice (Kovalchuk et al., 2007 (Kovalchuk et al., , 2012 Ramiro et al., 2004; Robbiani et al., 2008; Takizawa et al., 2008) .
Transcription facilitates AID targeting to Ig genes by at least three related mechanisms. First, Ig enhancers are required for hypermutation and recombination of both variable (V) domains and switch (S) DNA repeats that precede antibody gene constant (C) regions (Buerstedde et al., 2014) . Second, transcription of S repeats leads to substantial RNA PolII pausing (Rajagopal et al., 2009; Wang et al., 2009) , and Spt5, a PolII pausing factor, enables hypermutation and recombination by associating with AID (Pavri et al., 2010) . Third, the RNA degrading exosome complex displaces nascent S transcripts thereby rendering both DNA strands accessible to deamination (Basu et al., 2011) . Whether these or additional mechanisms are responsible for promiscuous AID activity at non-Ig loci is unknown.
Here, we examine promiscuous AID activity and its relationship to chromosome folding and the B cell regulome. We find that AID-mediated lesions occur predominantly within B cell super-enhancers and regulatory clusters. Furthermore, we show that the structural and transcriptional features of these domains help explain AID tumorigenic activity in the B cell compartment of mice and humans.
RESULTS

AID Damages Enhancer DNA
To study AID off-targeting activity, we made use of replication protein A chromatin immunoprecipitation (RPA-ChIP) that labels DNA breaks in the 53BP1 À/À background . B cells isolated from these mice are defective for nonhomologous end joining (NHEJ), and AID-mediated lesions that are induced in G1 are aberrantly processed in S and G2M by homologous recombination . As a result, DNA-ends are resected leading to asymmetrical accumulation of RPA and Rad51 around DNA breaks and these proteins can be detected by chromatin immunoprecipitation ( Figure 1A ) To improve the sensitivity of the assay, we developed an algorithm that detects asymmetric RPA recruitment with high precision, and the difference in ChIP signals between upper (+) and lower (À) DNA strands was plotted on a log scale ( Figure 1B) . The new approach revealed 92 additional genomic sites associated with RPA in 53BP1 À/À IgkAID B cells (236 total targets; Table S1A available online). Conversely, we detected a single RPA asymmetric peak in 53BP1 À/À AID À/À cells (not shown). At the Bcl11a locus, for instance, we found two additional sites downstream of the promoter (120 and 180 kb away) that display asymmetric RPA accumulation in the presence of AID but not in its absence ( Figure 1B ). Notably, a fraction of the peaks (33, or 14%) did not overlap with TSSs but were associated with DNaseI hypersensitive sites corresponding to B cell enhancers (red asterisks in Figure 1B ) . Consistent with this interpretation, AID targets distal from TSSs displayed the epigenetic signature of active enhancers: H2AZ low H3K4me3 low H3K4me1 high (Kouzine et al., 2013; not shown). Thus, in addition to promoter proximal sequences, AID damages enhancer DNA.
Nuclear Compartmentalization of AID Activity AID activity is confined to the interphase nucleus (Petersen et al., 2001) , where the genome is partitioned into a hierarchy of A B Figure 1 . AID Damages Enhancer DNA (A) Strategy to reveal AID-mediated breaks. In 53BP1 À/À cells DNA lesions at AID off-targets (e.g., Cd83) in G1 are resected in S and G2M by HR repair nucleases, leading to asymmetric RPA binding that can be detected by ChIP-Seq.
(B) The visualization of RPA-Seq was improved by plotting the difference in ChIP signals between + and -strands. An algorithm was developed to efficiently detect asymmetric RPA occupancy. The new approach reveals two additional AID targets at the Bcl11a locus that overlap with enhancer elements (highlighted with red asterisks). The nontargeted enhancer is marked with a blue asterisk. DNaseI, RNA (GRO-seq) (Chiarle et al., 2011) , and RPA control (53BP1
See also Figure S1 and Table S1A. structures, including A-B compartments, topologically associating domains (TADs), and clusters of interactive gene regulatory elements (Gibcus and Dekker, 2013) . The finding that both promoters and enhancers undergo AID-mediated damage suggests that AID targets might also be clustered in the B cell nucleus. In support of this idea, nearly half of all targets (110 of 236) were located within $90 kb of each other, a distance that is markedly different from a random model ($4 Mb, Figure S1A ). Prompted by these observations, we analyzed the distribution of RPA+ sites in the context of genome folding, as defined by chromosome conformation capture (3C) techniques.
Hi-C maps from pro-B cells (Lin et al., 2012) revealed that 96% of AID targets (233 of 236) are located within A compartments (Table S1A; Figure 2A ). These compartments are generally gene-rich, DNaseI-hypersensitive, and transcriptionally active (Lieberman-Aiden et al., 2009) , features that agree well with AID's preference for transcribed chromatin.
In eukaryotes, TADs divide A-B compartments into nuclear subdomains containing clusters of multiple regulatory elements tethered by long-range interactions (Gibcus and Dekker, 2013; Li et al., 2012) . To examine the distribution of AID targets vis-à -vis this architecture we made use of a PolII ChIA-PET map from activated B cells . This technique combines PolII ChIP with 3C technology to define the promoterenhancer interactome. Remarkably, while 47% of active promoters in B lymphocytes are not anchored in regulatory clusters, (Table S1A) In some cases, these clusters connected multiple AID targets. For instance, at the Pax5 locus the targeted promoter was linked by long-range interactions with three enhancer domains, one of which ($250 kb away) was also damaged by AID ( Figure 2C ). Likewise, the targeted Ly6a, Ly6e, and Rohema promoters in chromosome 15 formed a topological cluster spanning $100 kb ( Figure S1B ). Importantly, the vast majority of AID targets (84%) were tethered to regulatory elements within the same TADs (e.g., Pax5 cluster, Figure 2C ), consistent with the notion that these domains restrict chromatin mobility (Gibcus and Dekker, 2013) . A notable exception was the histone H1 gene family, where AID targets from two noncontiguous compartments physically associated over 2.1 Mb ( Figure S1C ). We conclude that AID preferentially damages promoters and enhancers tethered by long-range interactions within gene regulatory clusters.
AID Targeting Is Largely Confined to B Cell Super-Enhancers
Super-enhancers (SEs) or stretch enhancers were recently identified as a special subset of regulatory elements Lové n et al., 2013; Parker et al., 2013; Whyte et al., 2013) . They represent exceptionally large enhancer domains primarily associated with highly transcribed genes controlling cell identity. Because of the known correlation between transcription and AID activity, we asked whether regulatory clusters targeted by AID might represent SE domains. To this end, we used H3K27Ac and a published algorithm (Whyte et al., 2013) to catalog SEs in stimulated B cells. Consistent with the high degree of activation in the presence of LPS+IL-4, we uncovered 1,003 SEs in cultured B cells ( Figure S2A ). By comparison, 13% of 86 human tissues surveyed displayed >1,000 SEs . In agreement with such studies, activated B cell SEs spanned DNA regions an order of magnitude greater than conventional enhancers, and they were densely occupied by the Mediator complex ( Figure S2B ).
At all three Ig loci, AID-mediated damage occurred within SE domains interconnected by long-range interactions (Figures 3A and S2C) . Remarkably, 76% (179 of 236) of all AID targets were linked to SEs, a significant enrichment over what is expected by chance (p < 1 3 10 À15 , see Experimental Procedures).
As an example, both the Aicda-and Apobec1-targeted genes are interconnected within the same SE ( Figure 3C ). Thus, AID on-and off-targeting activity occurs primarily within SE domains. A key characteristic of SEs is that they are largely cell-type specific. Consistent with this, more than 50% of AID-targeted SEs were only present in stimulated B cells when compared to 18 primary mouse cells and tissues ( Figure S2D ). The analysis included SEs from developing pro-B cells (Whyte et al., 2013) , which only displayed 32% overlap with activated counterparts ( Figure S2D ). Hence, most AID-mediated damage occurs within SEs acquired during development.
Approximately 80% (824 of 1,003) of B cell SEs did not harbor AID-mediated damage ( Figure 3B ). Notably, SEs containing AID targets could be distinguished from nontargeted ones in that they were more accessible (higher H3K27Ac, p = 1 3 10 Figure 3E ), and their associated promoters were transcribed at higher levels (p = 4 3 10 À10 , Figure 3F ). In addition, the extent of 3D connectivity was significantly higher at targeted SEs (p = 3 3 10
À17
, Figure 3G ). We conclude that AID targets are preferentially associated with SEs displaying a high degree of accessibility, transcription, and structural complexity.
Functional Attributes of AID-Targeted Regulatory Elements
Within SEs, genes undergoing AID-mediated damage are linked to both targeted and nontargeted elements. For instance, of 11 enhancers associated with Myc, only two showed asymmetric RPA occupancy ( Figure 4A ). To characterize features that might distinguish these two enhancer groups, we measured hypersensitivity to DNaseI but found no significant differences (p = 0.9, Figure 4B ). Conversely, targeted enhancers were consistently transcribed, as determined by GRO-Seq analysis (p = 3 3 10 À5 , Figure 4C ). For instance, of the two enhancers upstream of Pax5, only the one displaying high levels of eRNA synthesis was associated with RPA, chromosomal translocations, and somatic hypermutation ( Figure 2C ). Additional examples at the Bcl11a locus are provided in Figure 1B . Similarly, the RPA+ Myc enhancers at the mid-point of Pvt1 were transcribed at higher levels compared to those lacking RPA ( Figure 4A ). Of note, Igk translocations involving this particular Myc enhancer cluster are selected during plasmacytomagenesis (Huppi et al., 2011) . Consistent with eRNA synthesis, PolII and PolII long-range interactions were significantly higher at enhancers associated with AID-mediated lesions (p = 2 3 10 À6 , Figure 4D and not shown).
The PolII stalling factor Spt5, implicated in AID recruitment (Pavri et al., 2010) , was also enriched in RPA+ enhancers (p = 6 3 10 À4 , Figure 4E ). Importantly, these features were particularly prominent at hypermutated Igh Em and Igk Ei enhancers, whereas they were consistently low at the nontargeted Igl E3-1 and E3-1 s enhancers (Figures 4C-4E ; Table S1B ). Conversely, no differences were found in the recruitment of CTCF, a factor involved in nuclear architecture (p = 0.03, Figure 4F ). A separate analysis showed that these same features distinguished AID-targeted from nontargeted promoters ( Figure S3A ). Thus, AID preferentially deaminates transcriptionally active promoters and enhancers that engage in frequent long-range interactions.
Interacting Targets within SEs Cooperate to Recruit AID Activity The clustering of AID targets in the mouse genome suggests that they may cooperate or synergize to recruit AID to SE domains. To directly test this idea we asked whether a nontargeted, but otherwise highly transcribed promoter could recruit hypermutation when linked to a damaged gene cluster. To this end, we inserted the ubiquitin-C (Ubc) gene promoter from chromosome 5 in lieu of the Il4ra promoter in chromosome 7 to generate Il4ra u/u mice ( Figure S3B ). In activated B cells, Il4ra and flanking NsmceI and Il21r overlap with SEs and interact extensively creating a multiple-promoter gene cluster ( Figure 5A ). In the presence of AID, all three genes undergo DNA double-strand breaks ( Figure 5A ), whereas no damage is detected at Ubc ( Figure S3C ).
Fluorocytometric analysis of Il4ra u/u and Il4ra +/+ B cells
showed comparable levels of cell surface Il4ra receptor (Figure S3D) . Consistent with this result, knockin B cells proliferated normally and underwent wild-type levels of g1 recombination ( Figures S3E and S3F ). Importantly, H3K27Ac and RNA-Seq showed little or no differences in SE location or expression of Nsmce1, Il4ra, or Il21r between the two cell types (Figures 5B, 5C, and S4A). To measure chromatin contacts at the knockin allele we applied an improved version of 4C-Seq that characterizes local architecture at high resolution (van de Werken et al., 2012) . The analysis showed that the knocked-in Ubc promoter associates with flanking Nsmce1 and Il21r genes at wild-type frequencies ( Figure S4B ). Similar results were obtained when using the Il21r promoter as bait ( Figure S4C ). Thus, neither transcription nor the architecture of the Nsmce1-Il4ra-Il21r locus appeared disrupted following promoter replacement.
To directly assess AID activity we bred the Il4ra u allele into the Ung
IgkAID background, which enables measurement of hypermutation in ex-vivo cultures . Il4ra IgkAID B cells were stimulated for 7 days and mutations downstream of Ubc were assessed at chromosomes 5 (native configuration) and 7 (knockin alleles). Consistent with the lack of DNA breaks at Ubc in chromosome 5 ( Figure S3C ), biological triplicates revealed background mutation at this site, comparable to the average PCR error rate measured in AID À/À cells (SHM(f) = 13.6 3 10 À5 versus 8.7 3 10 À5 ; Figure 5D ; Table S1B ). Notably, in Il4ra u/u cells
Ubc displayed a significant increase in mutation frequency in chromosome 7 compared to its native site (SHM(f) = 59.2 3 10 À5 , fold change = 4.3, p = 0.0005, Figure 5D ). This mutation frequency was nearly that of Il4ra in wild-type cells (80.5 3 10 À5 , Figure 5D ). Mir142, Pim1, and Myc, which are not directly associated with the Il4ra locus, showed no significant changes in hypermutation following gene targeting (fold change = 1.0-1.1, p > 0.7; Figure 5D ; Table S1B ). Hence, regulatory sequences at the Nsmce1-Il4ra-Il21r locus promote AID activity at Ubc. To determine whether the Il4ra promoter also facilitates AID activity at flanking genes, we measured hypermutation at Il21r and Nsmce1 in wild-type and knockin B cells. At Nsmce1, mutation could not be detected above background ( Figure 5D ). Conversely, at Il21r, where SHM(f) was 44.3 3 10 À5 in wildtype cells, we observed a statistically significant decrease in Il4ra u/u (13.2 3 10
À5
, p = 0.007, Figure 5D ), indicating that replacement of the Il4ra promoter for Ubc has a negative effect on mutation of Il21r more than 50 kb downstream. We conclude that both the Il4ra promoter and additional regulatory sequences at the Nsmce1-Il4ra-Il21r gene cluster enable off-targeting hypermutation by AID. The findings thus support a model where topologically linked elements within targeted SEs cooperate to recruit AID-mediated damage.
AID Targets in Human Lymphomas Overlap with Regulatory Clusters and SEs
Despite the known link between AID activity and human B cell tumor development (Klein and Dalla-Favera, 2008; Seifert et al., 2013) , a comprehensive map of AID targets in the human genome is lacking. To directly address this question and to validate our findings in mouse B cells we mapped AID activity in the Ramos Burkitt's lymphoma line and in primary diffuse large B cell lymphoma (DLBCL). These tumors derive from germinal center or postgerminal center B cells and frequently display evidence of AID activity (Lossos et al., 2004; Pasqualucci et al., 2004; Sale and Neuberger, 1998) . To efficiently detect hypermutation in Ramos we developed a deep-sequencing assay (SHM-Seq) by disrupting the mismatch repair gene MSH2 by genome editing with a cassette expressing AID and Ugi, an inhibitor of the base excision repair factor Ung ( Figure S5A ). The resulting cell line is therefore both Ung-and Msh2-deficient, a combination that in mouse B cells leads to high levels of AID-mediated transition mutations at Ig and off-target loci Liu et al., 2008) . Following 300 days of culture, the targeted cell line was single-cell sorted, individual clones were expanded, and DNA associated with H3K4me3, a histone mark that overlaps with AID activity , was isolated and microsequenced ( Figure S5A ). Nontargeted and AID À/À Ramos cells were used as controls. Analysis of 26 clones revealed 11,344 mutations relative to nontargeted and AID À/À controls. As expected, 92% of the substitutions were transitions. At IGH we detected 1,474 mutations (SHM(f) = 1.0 3 10 À2 ), mostly downstream of VDJ and Sm promoters ( Figure 6A ; Table S1C ). Likewise, the IGH-translocated MYC allele was highly mutated (SHM(f) = 5.0 3 10 À3 , Figure 6B ).
The nontranslocated MYC allele was also targeted but at a frequency $20-fold lower (SHM(f) = 2.2 3 10 À4 , not shown). Other oncogenes often targeted in human lymphomas showed evidence of AID activity, including MIR142, BCL6, BCL7A, MSH6, and ID3 (Table S1C ). In total, 60 sites were hypermutated with high confidence, including four conventional enhancers (false discovery rate [FDR] < 10 À16 , see Experimental Procedures).
Our mouse studies were performed with B cells overexpressing AID and in ex-vivo cultures, where SHM is limited. To map AID activity in unmanipulated cells we next performed wholegenome sequencing ($403 coverage) of ten DLBCL primary tumors isolated from lymph node biopsies. Somatic substitutions were defined by sequencing normal blood cells from the same patients. A total of 145,997 mutations were identified concomitant with deletions, insertions, amplifications, and chromosomal translocations. To classify AID hypermutation targets with high confidence we took advantage of the processive nature of AID deamination, which can generate clusters of transition mutations in individual clones (Lada et al., 2012; Taylor et al., 2013) . These mutation showers or kataegis were recently uncovered by whole-genome sequencing of B cell and nonhematopoietic tumors (Alexandrov et al., 2013; Bolli et al., 2014; Chen et al., 2014; Nik-Zainal et al., 2012; Sakofsky et al., 2014) . In the latter, particularly in breast tumors, kataegis was ascribed to processive deamination by the AID-related enzyme APOBEC3B (Alexandrov et al., 2013; Taylor et al., 2013) .
We identified 105 kataegic sites in DLBCL associated with 30 genes (Table S1D) . Four features implicated AID in the etiology of these mutation clusters. First, 82% of kataegis overlapped with transcribed promoter sequences, AID's preferred targeting domain ( Figure S5B ). This is in stark contrast to published non-B cell tumors (Alexandrov et al., 2013) , where <6% of the kataegis were associated with TSSs (p < 1 3 10 À10 , Figure S5B ). Second, also in contrast to other tumors, kataegis in DLBCL were recurrent, in that they always involved the IG loci and in most instances other mouse AID targets such as PIM1, PAX5, RHOH, CIITA, MIR142, BCL6, and the AID gene itself AICDA ( Figure 6C ; Table S1D ). Third, 71% of the mutations were C > T transitions, consistent with the notion that kataegis results from DNA replication over cytidine deamination of resected DNA (Sakofsky et al., 2014; Taylor et al., 2013) . Fourth, targeted cytidines bear the hallmark of AID activity , i.e., they occur in a sequence context that recapitulates AID's preference for WRCY hotspots (Chi-square test p < 1 3 10 À15 , Figure 6D ) (Rogozin and Kolchanov, 1992) . Conversely, mutated Cs in breast tumors only differed from the genome average in that they were preceded mostly by a T (Figure 6D ), consistent with the deamination profile of APOBEC3B (Alexandrov et al., 2013; Burns et al., 2013) . These results thus support the proposal that kataegis in human lymphomas stem from AID activity. We next characterized AID targets from Burkitt's and DLBCL tumors in the context of nuclear architecture and SEs. To this end we mapped PolII ChIA-PET and H3K27Ac in Ramos and used germinal center B cells isolated from human tonsils as substitutes for primary DLBCL (see Experimental Procedures). Consistent with the mouse results we found a strong overlap between hypermutated genes and SE domains (57%-70%, , see Experimental Procedures). Furthermore, 83%-85% of the targets were anchored by PolII longrange interactions ( Figure 6E ). For instance, at the BCL7A gene regulatory cluster in Ramos both the promoter and upstream enhancers were hypermutated ( Figure S5C ). Another notable example was the BCL6 promoter and a linked SE domain >250 kb upstream ( Figure 6F ). Importantly, while only the BCL6 promoter was associated with kataegis in DLBCL, a survey of 26 genomes from other primary human lymphomas (Alexandrov et al., 2013) revealed the presence of kataegis at the upstream SE domain ( Figure S5D ). Altogether, the results demonstrate that both in mouse and human B cells AID mutates tethered regulatory elements associated with SEs and regulatory clusters.
AID Targets a Specific Microenvironment Rather Than a Determined Set of Genes
The kataegis and SHM-Seq analyses of B cell tumors revealed that 57%-85% of human AID targets overlap with SEs and regulatory clusters, whereas the overlap with mouse targets was only 45%-53% ( Figure 6E ). The strong inference is that rather than mutating a specific set of genes, AID targets topologically complex, highly transcribed domains. To directly test this idea we mapped AID-induced translocations in MEFs using TC-Seq (Klein et al., 2011) Table S1E ). Similar to B cells (Klein et al., 2011) , a large fraction (20%-44%) of the rearrangements in MEFs occurred in cis within a 250 kb window around I-SceI (Figure S6A) . Furthermore, translocations were associated with genes more frequently than predicted by a random model (binomial test p < 0.0001, Table S1E ). Using stringent criteria, we identified 29 and 43 AID-dependent translocation hotspots in MEFs and B cells, respectively (Table S1F) . Remarkably, while the majority of these hotspots were genic (>84%), only three (11%) were shared between fibroblasts and lymphocytes ( Figure 7A ). This result indicates that the cell type alters the landscape of genomic rearrangements induced by AID. Because the spatial organization of the genome is not random but compartmentalized (Lieberman-Aiden et al., 2009) , it is possible that the cell type-restricted translocation to Myc I results from differences in nuclear organization. However, 4C-Seq showed that the Myc interactome in fibroblasts and lymphocytes was highly similar (Pearson's r = 0.88, Figure S6B ), consistent with the observation that nuclear interactions do not correlate with the frequency of AID-mediated translocations .
To explore the contribution of transcription to cell type-specific targeting, we next measured RNA synthesis. We found that, in general, genes associated with translocation hotspots displayed higher transcription in the respective cell type (Figure S6C) . For example, Pax5 and Cd83 were only targeted and expressed in B cells, while MEF-specific hotspots Ctgf and Wisp1 were only transcribed in fibroblasts ( Figure S6D ). Furthermore, while Myc was frequently translocated to the Igh I-SceI site in MEFs, we failed to detect rearrangements to S domains, which in fibroblasts are transcriptionally silent ( Figure S6E ). To assess whether differential AID targeting was also associated with SE domains we analyzed publicly available H3K27Ac profiles. We found that, similar to results obtained with B cells, AID activity at hotspot genes in MEFs occurred largely within the context of SEs (71%, p < 1 3 10 À10 , Figure 7B and Experimental Procedures). Importantly, this correlation applied to genes that were expressed in both cell types but were targeted in only one of them, such as Flnb on chromosome 14 ( Figure 7C ) and Pim1 on chromosome 17 ( Figure S7A ). Altogether, the findings demonstrate that whereas AID damages a different set of genes in MEFs and B cells, in both cell types the targets are preferentially associated with SEs domains.
DISCUSSION
Recurrent translocation to non-Ig loci in B cell cancers is due in part to DNA damage by AID (Chiarle et al., 2011; Hakim et al., 2012; Klein et al., 2011; Zhang et al., 2012) . However, the genomic features responsible for recruiting DNA damage are unknown. Our studies of mouse B cells, human lymphomas, and MEFs reveal that a major unifying property of AID targets is that they are predominantly clustered within highly active SEs and regulatory clusters ( Figure S7B ). As discussed below, the functional and architectural properties of these domains help explain why their associated genes are susceptible to AID tumorigenic activity. SEs represent a special subset of regulatory clusters, where chromatin accessibility and transcriptional activity are an order of magnitude higher than at other active sites (Parker et al., 2013; Whyte et al., 2013) . Both accessibility and transcription have long been recognized as prerequisites to Ig gene deamination (Alt et al., 2013) . Our experiments show that along with size and long-range interconnectivity, the presence of a SE can differentiate targeted from nontargeted regulatory elements. For instance, a model based on these combined features can Figure S5 and Tables S1C and S1D. accurately predict 91% of mouse AID targets at a false discovery rate of 9% ( Figure S7C ; Experimental Procedures). The underlying assumption is that, as a group, these properties help create a nuclear microenvironment highly suitable to AID-mediated deamination. The fact that our data cannot predict AID targeting in its totality implies that additional parameters might also be at play. Specific transcription factors for instance have been shown to facilitate AID recruitment to Ig genes (Buerstedde et al., 2014) .
Small RNA processing by the Exosome complex is another example (Pefanis et al., 2014) . Furthermore, in the accompanying paper, Alt and colleagues uncovers a strong correlation between convergent transcription and AID-mediated damage (Meng et al., 2014 
in this issue of Cell).
Another unexpected finding is that within targeted SEs AID not only damages promoter proximal sequences but also cognate enhancers. These are invariably transcribed and more frequently Tables S1E and S1F. anchored by PolII long-range interactions. Both features likely render enhancer DNA accessible to cytidine deamination and double-strand break formation. The link between AID activity and SEs sheds new light on the class of genes damaged in activated and germinal center B cells. Genome-wide maps of SHM, DNA breaks, and chromosomal translocations have consistently uncovered two sets of genes enriched among AID targets: oncogenes involved in proliferation and apoptosis (e.g., Myc, Pim1, Jund, Bcl2) and genes that feature prominently in B cell development and activation (Pax5, Cd79b, Aicda, Irf8, Bach2, Nfkb) . Although AID's predilection for these gene groups has been unclear, they fit well with the observation that in all tissues examined so far, SEs largely control expression of cell identity genes as well as oncogenes that regulate cell cycle and differentiation. Examples of these are pluripotency genes in ES cells, genes critical for islet function in the pancreas, and MYC in multiple myeloma (Lové n et al., 2013; Parker et al., 2013; Whyte et al., 2013) . By the same token, our TC-Seq analysis showed that targeted SEs in MEFs control expression of genes critical for fibroblast proliferation and maturation (e.g., Ctgf, Wisp1, Amotl2).
Another defining feature of SEs is that their constituent regulatory elements work in cooperation or synergistically to drive gene expression (Lové n et al., 2013) . Our knockin experiments between the nontargeted Ubc promoter and the Nsmce1-Il4ra-Il21r targeted gene cluster provide compelling evidence that cooperation is also key to promiscuous AID-mediated damage. This feature helps explain why AID targets are clustered in the B cell genome. At the same time, it suggests that only networks of functionally cooperating elements can create the proper conditions for AID promiscuous activity. It is important to point out that these conditions are not exclusive to SE domains, but that they also typify highly interactive regulatory clusters not directly associated with SEs (e.g., H1 gene family). The Ubc-Il4ra experiment also provides a rationale to earlier observations showing that heterologous promoters not typically damaged in germinal centers (e.g., b-globin, B29, or PolI promoters) can recruit hypermutation when juxtaposed to Ig enhancers (Betz et al., 1994; Fukita et al., 1998; Tumas-Brundage and Manser, 1997) . In both cases, AID exploits long-range interactions to act at a distance on nontargeted sequences.
In conclusion, rather than targeting a predetermined gene set, AID tumorigenic activity is focused on nuclear microenvironments that share a common set of architectural, transcriptional, and regulatory features.
EXPERIMENTAL PROCEDURES
Extended Experimental Procedures are provided in the Supplemental Information section.
4C-Seq
The 4C assay was performed as previously described van de Werken et al. BioLabs DpnII buffer) containing 0.3% SDS. To sequester SDS, Triton X-100 was then added to a final concentration of 1.8%. DNA digestion was performed with 400 U of DpnII (New England Biolabs) at 37 C overnight. After heat inactivation (65 C for 30 min), the reaction was diluted to a final volume of 7 ml with ligation buffer containing 100 U T4 DNA Ligase (Roche) and incubated at 16 C overnight. Samples were then treated with 500 mg Proteinase K (Ambion) and incubated overnight at 65 C to reverse formaldehyde crosslinking. DNA was then purified by phenol extraction and ethanol precipitation. For circularization, the ligation junctions were digested with Csp6I (Fermentas) at 37 C overnight.
After enzyme inactivation and phenol extraction, the DNA was religated in a 7 ml volume (1,000 U T4 DNA Ligase, Roche). Three micrograms of 4C library DNA was amplified with Expand Long template PCR System (Roche). Thermal cycle conditions were DNA denaturing for 2 min at 94 C, followed by 30 cycles of 15 s at 94 C, 1 min at 58 C, 3 min at 68 C, and a final step of 7 min at 68 C. Baits were amplified with inverse PCR primers as follows: Il4ra with DpnII: _4C 5 0 -TCAGGTAGTTCCATGGGATC-3 0 , Il4ra_Csp6i 5 0 -ATCTCTGCACCAGA-CATCAG-3 0 and Il21r with IL21r_DpnII CCAGACCTACTTAGCAGATC, and IL21r_Csp6i: ACTTAGACACTGCTCAGCTG. 4C-amplified DNA was microsequenced with the Illumina platform.
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